However, CJC-1295 (especially the DAC version) can cause sustained elevation in IGF-1, whichif mismanagedmay increase the risk of: Insulin resistance Carpal tunnel syndrome Soft tissue growth (in rare, prolonged cases) Pituitary overstimulation That said, these issues are more often associated with excessive dosing or continuous high-frequency use
For a fraction of the cost of a private course, you get a clear answer
Contraception Counseling : Women using oral hormonal contraceptives should use an additional non-hormonal contraceptive method for 4 weeks after initiating tirzepatide and for 4 weeks after each dose increase
As with all research peptides, the absence of long-term human safety data means dose, duration, and cycling decisions should be made with a licensed provider familiar with the published literature
R., DAlessio, D., Drucker, D